Rank #1842BOLT

Bolt Biotherapeutics, Inc.

$5.13

9.85% (Daily)

Market Cap

$9.85M

Revenue

$5.20M

Rank by MCap

#1842

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. William P. Quinn

Headquarters

Redwood City, CA

Employees

About Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company dBDC-3042, develops dan agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer; and BDC-4182, an next-generation boltbody technology platform that targets claudin 18.2, which is overexpressed in gastric/gastroesophageal junction cancer, pancr...